Wellmedr vs bmiMD: Pricing, shipping, and plan differences

Comparing Wellmedr vs bmiMD quickly: Wellmedr advertises semaglutide plans starting at $89/month with lifetime locked pricing and marketing claims like same day review and free overnight shipping; bmiMD advertises compounded tirzepatide with multi month pricing that can be as low as $139/month on a 12 month plan with free subscription shipping. Early verdict: Wellmedr emphasizes lower semaglutide entry pricing and locked pricing benefits while bmiMD emphasizes structured multi month tirzepatide pricing and free shipping.

See Wellmedr semaglutide plans from $89/mo

Wellmedr vs bmiMD: what differs most

This comparison focuses on the most distinctive supported differences: starting price and pricing structure, medication focus and dose pricing, shipping and refill promises, clinician access and review timing, and regulatory notes about compounded medications. All statements below reflect only the supplied source information.

1. Starting price and billing options

Wellmedr lists semaglutide plans starting at $89/month and advertises specific promotional pricing and lifetime locked pricing. bmiMD lists tirzepatide monthly equivalents with multiple billing options and a lowest long term monthly equivalent of $139/month for a 12 month plan. bmiMD also documents month to month prices that are higher without a long term commitment.

2. Medication focus and dose pricing

Wellmedr presents semaglutide and tirzepatide offerings, with marketing copy including Tirzepatide monthly plan starting at $89 and Semaglutide monthly plan starting at $49 in landing content. The provider notes compounded GLP-1 medications are offered. bmiMD presents compounded tirzepatide specifically, with the claim of the same price at every dose and a multi month price schedule: $179 month to month, $159 for three months, $149 for six months, and $139 for 12 months.

3. Shipping, refill cadence, and timing

Wellmedr claims same-day review plus free overnight shipping in short bullets and states tirzepatide is shipped every 4 weeks and semaglutide shipped every 4 weeks for monthly plans. bmiMD states free subscription shipping on every order and online refills and delivery timed to when you need them.

4. Clinician review and access

Wellmedr advertises same-day review and notes all treatment plans require medical evaluation and clinician approval. bmiMD advertises 24/7 clinician access and clinician-reviewed online weight management with eligibility subject to a licensed clinician determining medical appropriateness.

5. Regulatory and safety notices

Both providers include the regulatory note that compounded medications are not FDA approved and are not reviewed by FDA for safety, effectiveness or quality. Wellmedr provides an explicit safety notice that compounded medications are regulated by state Boards of Pharmacy but are not evaluated by the FDA for safety or efficacy and lists specific GLP-1 medication risks and the need for medical evaluation. bmiMD states that compounded medications, when offered, are not FDA approved and are not reviewed by FDA for safety, effectiveness or quality.

Side by side at a glance

Criteria	Wellmedr	bmiMD
Starting price cited	Semaglutide from $89/month; marketing shows multiple starting prices	Tirzepatide from $139/month on 12 month plan; $179 month to month
Pricing structure	Lifetime locked-in pricing; no dose based price increases claimed	Four billing options with lower long term monthly equivalent for longer commitments
Shipping and refills	Same-day review plus free overnight shipping; shipments every 4 weeks	Free subscription shipping on every order; online refills and delivery
Clinician access	Same-day clinician review; treatment requires clinician approval	24/7 clinician access and clinician-reviewed online programs
Regulatory note	Compounded meds from licensed U.S. pharmacies; not reviewed by FDA for safety or efficacy	Compounded meds not FDA approved nor reviewed by FDA for safety or effectiveness

Practical differences when choosing

If your primary consideration is lowest advertised semaglutide entry pricing or lifetime locked pricing language, Wellmedr presents semaglutide plans starting at $89/month and highlights lifetime locked-in pricing and no dose based price increases. If you are evaluating tirzepatide specifically and anticipate committing to a longer plan to lower the monthly equivalent, bmiMD documents structured multi month pricing that reaches $139/month on a 12 month plan and includes free subscription shipping and 24/7 clinician access.

View Wellmedr plans and shipping details

Explore bmiMD tirzepatide billing options

Cost commitments and risks to confirm

Wellmedr marketing includes promotional language about locking in discounts for life and a money back guarantee claim on weight loss in 90 days in landing content; verify terms directly with the provider. bmiMD highlights that the lowest price requires a 12 month commitment and that total prepaid charge should be confirmed. Both providers state that treatment is available only when a licensed clinician determines it is medically appropriate and both note compounded medications are not FDA approved.

Check Wellmedr eligibility and offers

Conclusion: Wellmedr vs bmiMD

Wellmedr vs bmiMD boils down to whether you prioritize lower advertised semaglutide entry pricing plus lifetime locked pricing language or structured multi month tirzepatide pricing with free subscription shipping and 24/7 clinician access. Both offer clinician review and provide compounded medications with regulatory notices that these products are not FDA approved.

Choose Wellmedr if you prioritize lower semaglutide starting prices, lifetime locked-in pricing language, and same-day review plus overnight shipping claims. Choose bmiMD if you want tirzepatide with multi month pricing tiers that lower the monthly equivalent to $139 on a 12 month plan, free subscription shipping, and 24/7 clinician access.